The data showed that CD8+ T cells in the combination therapy group had a markedly enhanced capacity to secrete key cytokines, including IFN‐γ and TNF‐α, both of which are essential for effective anti‐tumor immunity (Figure 4k,l). Here, CD8A is linked to neoplasm.